TY  - JOUR
PY  - 2021//
TI  - Suicide attempt in a patient with sibutramine associated psychosis
JO  - Acta medica Portuguesa
A1  - Câmara Pestana, Pedro
A1  - Ferreira, Carla
A1  - Santos, Ana Luísa
A1  - Jerónimo, Joana
A1  - Ganança, Licínia
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - Sibutramine is a serotonin-norepinephrine-dopamine reuptake inhibitor, initially developed as a potential antidepressant and later approved for the management of obesity. Sibutramine use is also associated with psychiatric symptoms, namely mania, panic attacks, and, less frequently, psychosis. We report the case of a 32-year-old man, admitted to our hospital due to a suicide attempt in the context of sibutramine-associated psychosis. The symptoms remitted completely after discontinuation of sibutramine and a brief period of antipsychotic medication. The aim of this manuscript is to highlight the importance of the recognition of sibutramine-associated psychosis, to discuss the possible pathophysiology and the proper clinical and therapeutic management.<p />  <p>Language: en</p>
LA  - en
SN  - 0870-399X
UR  - http://dx.doi.org/10.20344/amp.14304
ID  - ref1
ER  -